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CURRENT REVIEW IN BASIC SCIENCE
NEW ROLES FOR INTERLEUKIN-1 BETA
IN THE MECHANISMS OF EPILEPSY
Annamaria Vezzani, PhD,1 and Tallie Z. Baram, MD, PhD2
1Laboratory of Experimental Neurology, Department of Neu-
roscience, Mario Negri Institute for Pharmacological Research,
Milano, Italy; 2Departments of Anatomy, Neurobiology and
Pediatrics, University of California at Irvine, Irvine, California
The mechanisms that transform a normal brain to an epileptic one
are not fully understood. Interleukin-1 beta (IL-1β) contributes
to neuronal degeneration observed in several neurological disor-
ders and recently has been implicated in neuronal injury that may
accompany the process of epileptogenesis. This review presents the
hypothesis that IL-1β may contribute to the development of epilepsy
via several mechanisms, including classical effects on neuronal sur-
vival and transcription pathways; novel rapid effects on receptor-
gated ion channels; and long-lasting effects on expression of selective
gene families. Thus, evidence that IL-1β actions in epilepsy can be
independent from the neurotoxic effects of this cytokine is presented.
An understanding of the role of inflammatory processes,
particularly of the cytokines, in human neurological diseases has
been evolving. For example, inflammatory processes are now
considered key contributors to acute and chronic neurodegen-
erative disorders, such as ischemic stroke and Alzheimer’s disease
(1). Insight into the many faceted roles of the cytokines, espe-
cially of interleukin-1 beta (IL-1β), in the initiation and pro-
gression of neuronal dysfunction has been gained from studies
of the evolution of epilepsy. In respect to the pathophysiol-
ogy of the epilepsies, clinical studies, in vivo models, in vitro
molecular and imaging data, gene arrays, and the use of genet-
ically engineered mice (2) are leading to a radically modified
view of the role of cytokines in epileptogenesis, which may be
germane to many other neurological diseases. Key questions in-
clude whether cytokines synthesized and released as a result of
cell injury or during and after seizures contribute to the disease
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process itself, and if so, then how. In this short review, the evi-
dence from studies on the mature and developing rodent brain
of a role for IL-1β in epileptogenesis is examined.
Potential Roles of IL-1β in Epileptogenesis
Epileptogenesis, a transformation of a nonepileptic neuronal
circuit to a seizure-generating one, is a complex process involv-
ing several key components:
Hyperexcitability of Neurons and of Neuronal Circuits
This phenomenon is particularly well defined in temporal lobe
epilepsy (3). The formation of a hyperexcitable circuit may de-
pend on the severity and duration of the initial inciting event
in the case of acquired epilepsy or on the nature and extent
of structural (e.g., cerebral malformation) or functional (e.g.,
mutated ion channel) abnormality in the case of epilepsies in-
volving genetic causes. Cytokines released during the inciting
insult may directly contribute to hyperexcitability. In addition,
recurrent seizures during the epileptic phase may further release
cytokines, promoting progression of the hyperexcitable state.
Seizure-Evoked Excitotoxicity
In the mature brain, the inciting event (often status epilepti-
cus) leads to substantial loss of vulnerable neurons within the
hippocampal formation; this loss is considered by many to be
required for epileptogenesis (3). Cytokines and other inflam-
matory mediators have been shown to contribute to neuronal
death (1,2). Therefore, they may participate in the epilepto-
genic process via augmentation or mediation of seizure-evoked
cell death.
Other Putative Pro-Epileptogenic Processes
Epileptogenesis that is independent from neuronal death has
been found in several genetic epilepsy models (e.g., genetic ab-
sence epilepsy rats from Strasbourg [GAERS], WAG/Rij) (4).
Similarly, only minimal cell death is found after kindling (5,6) or
in epilepsy evoked by experimental febrile seizures in immature
brain (7,8). A role for cytokines in this epileptogenic process
would not include excitotoxicity and might derive from other
established or nonconventional effects of interleukin signaling.
The following paragraphs briefly review information about
IL-1β contribution to excitability and excitotoxicity as well as
introduce potential novel roles of this cytokine in epileptogen-
esis.
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Studies in Adult Animal Models of Temporal
Lobe Epilepsy
Temporal lobe epilepsy can be modeled in adult rodents by
provoking seizures or status-epilepticus. In these models, there
is evidence of neuronal death, the reactive formation of new
synapses, and the molecular and functional reorganization of
a previously normal circuit into an epileptic one (3). Further-
more, these models have been useful in probing the potential
roles of cytokines in the epileptogenic process. Seizures and
status epilepticus induced by chemical or electrical means stim-
ulates a massive inflammatory response in the brain that con-
sists of increased levels of cytokines, including IL-1β. Unlike
the inflammatory response caused by endotoxemia—which is
confined to the choroid plexus, vessels, and microglia—the in-
flammatory response after seizures also involves neurons and as-
trocytes and occurs specifically in brain regions of seizure onset
and propagation. The CNS inflammatory response following
seizures is rapid (within an hour) and long-lasting (2). In addi-
tion, a unique facet of the inflammatory response to seizures is
the time course of induction of activators and repressors of the
IL-1β receptor: when released, IL-1β binds with high affinity
to the type 1 IL-1 receptor (IL-1R1) that is expressed by hip-
pocampal neurons (9–11). In typical peripheral inflammatory
reactions, the production of IL-1β is accompanied by concomi-
tant synthesis of 100- to 1000-fold excess of the endogenous
IL-1R antagonist (IL-1RA), which rapidly occludes the activa-
tion of this receptor (12). In contrast, when seizures evoke rapid
production of IL-1β, IL-1RA is upregulated to a far lower ex-
tent and with a several hour delay (13,14). This finding suggests
that the brain is much less effective than the periphery in in-
ducing a crucial mechanism for rapidly terminating the effects
of a sustained rise in endogenous IL-1β.
Nonconventional, Rapid Actions of IL-1β on
Neuronal Excitability
Findings from in vivo experiments support a role for IL-1β sig-
naling in hyperexcitability because IL-1β exacerbates seizures
in rodents when applied intracerebrally shortly before kainic
acid or bicuculline administration (15,16). In contrast, IL-1RA
acts as an anticonvulsant, and in IL-1RA–overexpressing mice,
seizure onset is delayed and seizure spread is strongly attenu-
ated (16,17). In addition, seizures are reduced by blocking the
formation of the biologically active form of IL-1β by selective
inhibition of interleukin-1 converting enzyme (ICE or caspase-
1) or by enzyme gene deletion (18).
How does lL-1β that is released during the inciting in-
sult contribute to hyperexcitability, and how might it promote
progression of the hyperexcitable state? The in vivo effects in
experimental models occur within a few minutes of the applica-
tion of the cytokines; therefore, they cannot be explained by the
classic signaling cascade involving activation of genomic tran-
scriptional events (12). Rather, these effects are consistent with
direct actions of IL-1β on ion channels and neurotransmitter
receptors.
Recent elegant studies involving the effects of IL-1β on the
activity of warm-sensitive neurons in the preoptic area and the
anterior hypothalamus have shown that IL-1β signaling occurs
through a rapid nontranscription-dependent enzymatic path-
way. This pathway includes the IL-1R1–mediated activation of
the neutral sphingomyelinase (19) and the subsequent produc-
tion of ceramide, which in turn activates the tyrosine kinase
protein, Src. Interestingly, IL-1β enhances calcium influx into
hippocampal pyramidal cells exposed to N -methyl-D-aspartate
(NMDA) by phosphorylation (via Src kinase) of the NR2B
subunit of the NMDA receptor complex, which is responsible
for regulating its calcium permeability properties (20). Results
from this study suggest that ceramide may be the second mes-
senger of the rapid IL-1β actions on neuronal excitability. In the
hippocampus, this mechanism may constitute the basis of the
proconvulsant actions of the cytokines observed in the in vivo
experimental models that are dependent on NMDA receptor
activation (15). In addition, IL-1β inhibits glutamate reuptake
by astrocytes (21) and enhances its astrocytic release via tumor
necrosis factor-alpha (TNF-α) induction (22). TNF-α also can
increase AMPA-receptor density at the neuronal membrane in
a molecular conformation lacking the GLUR2 subunit, which
results in enhanced calcium influx (23). Astrocytic glutamate
release recently has been implicated in the generation of epilep-
tiform activity (24). It is intriguing to speculate that IL-1β may
play a role.
Seizure-Evoked Excitotoxicity
Specific cytokines, including IL-1β, have been shown to con-
tribute to neuronal injury in traumatic, ischemic, and excito-
toxic conditions (1), perhaps in part via enhanced excitability.
Although degenerating neurons may promote and perpetuate
the production of cytokines, so that a vicious cycle of neu-
ronal injury and inflammation is activated, it is important to
note that IL-1β induction following seizures always precedes
the occurrence of irreversible cell death. In addition, IL-1β af-
fects blood–brain barrier permeability and induces immune cell
infiltration into the brain (1,2). These phenomena have been
found to promote hyperexcitability (24,25) as well as excitotox-
icity (26).
In summary, studies of epileptogenesis in adult rodent
models provide compelling evidence of a role for IL-1β. How-
ever, because the cytokine promotes both hyperexcitability and
excitotoxicity and because both processes take place during
epileptogenesis, it is difficult to sort out what elements of the
actions of IL-1β are crucial, that is, required and sufficient
for its contribution to the generation of spontaneous recurrent
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seizures. Increased production of inflammatory molecules in
the brain have been reported after fully kindled seizures (27)
and in genetic models of audiogenic seizures (28)—situations
in which epileptogenesis is independent from neuronal death.
A role for IL-1β in the epileptogenic process in these scenarios
would not include excitotoxicity and might derive from other
established effects of interleukin signaling. In the next section,
such roles for IL-1β in the epileptogenic process are examined
on the basis of the studies involving immature animal models
of seizures and epileptogenesis.
Studies in Immature Animal Models of Epilepsy:
Mismatch between Excitotoxicity and Epileptogenesis
Over the past 20 years, the majority of studies that have used
animal models of developmental epilepsies generally have sup-
ported the view that the crucial contribution of cytokines to
epileptogenesis involves their effects on excitotoxicity. Most of
these studies demonstrated that status epilepticus—provoked
during the age of hippocampal development equivalent to that
of the human infant (i.e., prior to postnatal day 14–15 in the rat
[29])—failed to trigger the onset of epilepsy later in life. Absence
of the epileptogenic process was associated with commensurate
absence of significant cell death in the hippocampus (30–32)
and with a lack of up-regulation of endogenous IL-1β (32),
which is consistent with the hypothesis that IL-1β–mediated
excitotoxicity is a key mechanism in the epileptogenetic process.
In contrast, an infant rodent model of human childhood
prolonged febrile seizures recently has been defined; in this
model (as is likely in humans), IL-1β intrinsically contributes
to the generation of the seizures (33) and the inciting seizures
do evoke epileptogenesis (8). Remarkably, excitotoxicity (i.e.,
cell death) does not accompany the epileptogenic process, indi-
cating that cell death is not required for epilepsy generation
(7,8,30,31). Thus, the developmental febrile seizures model
dissociates the mechanisms of the pro-epileptogenic actions of
IL-1β from excitotoxicity.
Fever, Febrile Seizures, and IL-1β
Fever is a systemic host response to infection, inflammation,
or stress (12). Fever provokes convulsions (febrile seizures) in
3–5% of young children in the western world and in up to
14% in Japan (34). The mechanisms by which fever evokes
febrile seizures are not fully elucidated, but a role for IL-1β is
supported by several lines of evidence. First, IL-1β produced
from peripheral and potential brain sources is involved in the
pyrogenic process leading to fever (35). Indeed, levels of the
cytokine have been reported to increase in CSF of children with
febrile seizures (36), although these data are controversial (37–
39), and some studies have suggested that genetic variance that
enhances IL-1β expression promotes the occurrence of febrile
seizures, a notion that also has been challenged (40).
Direct evidence for the role of endogenous IL-1β in the
induction of febrile seizures is provided by studies from ani-
mal models. For example, in a rodent model of febrile seizures,
the ablation of the gene for IL-1R1 interferes with the abil-
ity of hyperthermia to evoke experimental febrile seizures (33).
Moreover, the intracerebral application of IL-1β in immature
rodents decreases the threshold for induction of experimental
febrile seizures (33). It is notable that cells in the hippocam-
pus, a region contributing to the origin and spread of febrile
seizures, synthesize IL-1β in response to fever or hyperther-
mia (41–43). Remarkably, IL-1β is not synthesized or released
during other types of experimental seizures in the immature ro-
dent (e.g., those induced by KA). Experimental febrile seizures
provoke long-lasting alterations in the expression of several in-
trinsic neuronal genes and promote epileptogenesis. Therefore,
is it postulated that hyperthermia-evoked release of endogenous
IL-1β acutely enhances neuronal excitability and leads to more
enduring alterations in the transcription of specific genes, via
activation of the mechanisms depicted in Figure 1.
Febrile Seizures and Epileptogenesis:
The Clinical Conundrum
Prolonged human febrile seizures are associated statistically with
the development of temporal lobe epilepsy (44). Retrospective
(but not prospective) analyses suggest that approximately 30–
70% of individuals with temporal lobe epilepsy have a history
of these seizures early in life (44–47). This fact makes under-
standing the mechanisms of epileptogenesis generated by febrile
seizures an important clinical problem. As mentioned, direct ev-
idence for febrile-seizures–evoked epileptogenesis has been pro-
vided by an animal model (8) that permits mechanistic analysis
of the role of IL-1β in this process. Because epileptogenesis af-
ter experimental febrile seizures does not require excitotoxicity,
other mechanisms are likely to contribute to this pathogenic
process.
Figure 1 summarizes the putative pro-epileptogenic actions
of IL-1β–mediated by IL-1R1 activation. These events occur
during the process of epileptogenesis, regardless of whether ex-
citotoxicity and cell death take place (as in adult poststatus
epilepticus epileptogenesis) or not (as in immature brain after
febrile seizures or in genetic epilepsy models).
1. Classical signaling cascades include the mitogen-
activated protein kinases (MAPKs) and NF-κB–
dependent pathways that lead to increased gene tran-
scription. The genomic effects of IL-1 β contribute to
enduring alterations in gene expression programs that
may underlie the epileptogenic process and may occur
even without cell death or overt structural changes.
It has been postulated that the long duration of the
seizure-evoked release of IL-1β (48) may account for the
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FIGURE 1. IL-1β and Epileptogenesis. This schema depicts the
cascade of events that may underlie CNS actions of IL-1β after its
production and release following a precipitating event. Brain IL-1β
is mainly produced by glia (microglia and astrocytes); endothelial
cells of the blood–brain barrier, neurons, and lymphocytes represent
additional sources. Since the same cells that produce IL-1β also ex-
press IL-1 type 1 receptors (IL-1R1), it appears that this cytokine is
endowed with both autocrine and paracrine actions. Activation of
IL-1R1 by IL-1β can trigger rapid effects on neuronal excitability,
leading to rapid ion channel changes mediated by activation of ki-
nases, such as Src and phosphoinositol 3 kinase (PI3K) (19,20,23).
These actions are likely to be responsible for the proconvulsive ac-
tions of IL-1β and may contribute to seizure-associated neuronal
death. Long-term effects also may be triggered by IL-1β via transcrip-
tional activation of NF-κB- and MAPK-dependent genes involved in
structural and functional changes in glial and neuronal networks.
These actions, individually or in concert, may contribute to epilep-
togenesis. However, available experimental evidence indicates that
induction of neuronal cell death does not appear to be a prerequisite
for the pro-epileptogenic actions of IL-1β.
enduring effects of the cytokine on gene expression of re-
ceptors and ion channels (49,50).
2. The novel, direct actions of IL-1β on neuronal transmis-
sion strongly suggest that it may contribute significantly
to lowering the threshold for neuronal excitability, thus
playing a role in the onset and recurrence of spontaneous
epileptic events.
3. Both genomic and rapid effects of IL-1β may impact cell
survival as well as the consequent structural and func-
tional reorganization of neuronal networks. However,
available experimental evidence indicates that induction
of neuronal death does not appear to be a prerequisite
for the pro-epileptogenic actions of IL-1β.
In conclusion, the spectrum of mechanisms by which
IL-1β may contribute to epilepsy is increasing as refinement of
tools permits dissection of not only overt effects (e.g., cell death)
but also of subtle and pervasive alterations of cellular function.
Pharmacological investigations using the available tools to block
endogenous IL-1β production and/or its cell signaling after the
inciting event in experimental models of acquired epilepsies are
required to define better the role and relevance of this cytokine
in epileptogenesis (15,16,18).
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